SLC30A1 and cancer: Comparative analysis of mRNA levels of ZnT1 in tumor specimens and healthy individuals revealed that there is a significant ZnT1 overexpression in specimens from various cancers including ESCA, thymoma, PAAD, READ, and STAD (Fig. 2).